Wang Y, Lv BJ, Li K, Zhang AQ, & Liu H. (2017). Adjuvant immunotherapy of dendritic cells and cytokine-induced killer cells is safe and enhances chemotherapy efficacy for multiple myeloma in China: A meta-analysis of clinical trials. Dove Medical Press.
Chicago Style (17th ed.) CitationWang Y, Lv BJ, Li K, Zhang AQ, and Liu H. Adjuvant Immunotherapy of Dendritic Cells and Cytokine-induced Killer Cells Is Safe and Enhances Chemotherapy Efficacy for Multiple Myeloma in China: A Meta-analysis of Clinical Trials. Dove Medical Press, 2017.
MLA (9th ed.) CitationWang Y, et al. Adjuvant Immunotherapy of Dendritic Cells and Cytokine-induced Killer Cells Is Safe and Enhances Chemotherapy Efficacy for Multiple Myeloma in China: A Meta-analysis of Clinical Trials. Dove Medical Press, 2017.